Sign inJoin waitlistJoin the waitlist

Joshua Sasine

Principal Investigator · Cedars-Sinai Medical Center

Credentials: · · · · · · ·

History

University of Florida College of Medicine
2025–Present

Hematology and Medical Oncology
2014–2017
Internal Medicine
2011–2014
Univ of Miami Leonard M. Miller Sch of Med
2007–2011
University of California, Irvine (UCI

Research

Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma
Blood Advances · 2020 · 376 citations
Distinct Bone Marrow Sources of Pleiotrophin Control Hematopoietic Stem Cell Maintenance and Regeneration
Cell stem cell · 2018 · 121 citations
Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy
Cell Reports Medicine · 2021 · 109 citations

John Chute
13 papers
Aaron Logan
8 papers
BS
Bijal Shah
8 papers
Gary Schiller
8 papers
Gregory Roloff
8 papers · 4 as a fellow
Ibrahim Aldoss
8 papers
KD
Kaitlyn Dykes
8 papers · 8 as a fellow
Lori Muffly
8 papers
Marc Schwartz
8 papers
MS
Melhem Solh
8 papers
Muthu Kumaran
8 papers
Noelle Frey
8 papers

Grants

Decoupling Bidirectional EphB/ephrinB2 in Multiple Myeloma
National Cancer Institute · K08
Contact PI · $1.3M · Cedars-Sinai Medical Center
2020–2025

Clinical trials

Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies
Principal investigator · Recruiting · Phase 1
Joshua Sasine, MD, PhD
2024–2027
Post-Transplant Cyclophosphamide in Patients Aged >/= 65 Years Undergoing Haploidentical Transplant
Sub-investigator · Recruiting · Phase 1
Ronald Paquette
2023–2028